Michael Sanatani

886 total citations
46 papers, 431 citations indexed

About

Michael Sanatani is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Michael Sanatani has authored 46 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 10 papers in Surgery. Recurrent topics in Michael Sanatani's work include Lung Cancer Treatments and Mutations (8 papers), Cancer survivorship and care (8 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Michael Sanatani is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Cancer survivorship and care (8 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Michael Sanatani collaborates with scholars based in Canada, United States and Australia. Michael Sanatani's co-authors include Larry Stitt, George Rodrigues, Mark Vincent, Jawaid Younus, Brian Yaremko, B. Dingle, A. Rashid Dar, Richard Malthaner, David Massel and K. Unsworth and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Michael Sanatani

42 papers receiving 427 citations

Peers

Michael Sanatani

ONCOL

PRM

PPCH

RNMI

SURGE

Randy V. Heysek United States

Tai‐Chung Lam Hong Kong

C. Louzado Canada

H. Bülzebruck Germany

Joanna B. Madalinska Netherlands

Sidney Davis Australia

William Quarshie United States

Stefanie Kreissl Germany

Claudio Verusio Italy

R Russell Canada

Randy V. Heysek United States

Michael Sanatani

232 ×1.4

ONCOL

242 ×1.4

PRM

34 ×0.4

PPCH

27 ×0.5

RNMI

40 ×0.7

SURGE

Citations per year, relative to Michael Sanatani Michael Sanatani (= 1×) peers Randy V. Heysek

Countries citing papers authored by Michael Sanatani

Since Specialization

Citations

This map shows the geographic impact of Michael Sanatani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Sanatani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Sanatani more than expected).

Fields of papers citing papers by Michael Sanatani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Sanatani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Sanatani. The network helps show where Michael Sanatani may publish in the future.

Co-authorship network of co-authors of Michael Sanatani

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Sanatani. A scholar is included among the top collaborators of Michael Sanatani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Sanatani. Michael Sanatani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Jane H.-C., et al.. (2024). Combination of Osimertinib and Olaparib Therapy to Treat Non-Small Cell Lung Cancer and High-Grade Serous Ovarian Carcinoma: A Case Report. Current Oncology. 31(1). 558–565. 1 indexed citations

Sanatani, Michael, et al.. (2024). Twelve tips for the transition from training to first faculty position. MedEdPublish. 14. 42–42.

Sanatani, Michael, et al.. (2023). The oncology ribbon of reflection: a novel tool to encourage trainee self-reflection. SHILAP Revista de lepidopterología. 15(2). 86–87. 1 indexed citations

Schenkel, Laila C., et al.. (2023). Double Duty: Complete Pathologic Response of Two Colonic Primaries with Mosaicism of a Novel MLH1 Mutation to Neoadjuvant Pembrolizumab. Current Oncology. 30(10). 9039–9048.

Sanatani, Michael, Daniel Breadner, Carolyn D. Scott, et al.. (2023). Real-World Analysis of Durvalumab after Chemoradiation in Stage III Non-Small-Cell Lung Cancer. Current Oncology. 30(8). 7713–7721. 10 indexed citations

Yu, Edward, Alison L. Allan, Michael Sanatani, et al.. (2022). Circulating tumor cells detected in follow-up predict survival outcomes in tri-modality management of advanced non-metastatic esophageal cancer: a secondary analysis of the QUINTETT randomized trial. BMC Cancer. 22(1). 746–746. 9 indexed citations

Yaremko, Brian, Dante P. I. Capaldi, Khadija Sheikh, et al.. (2022). Functional Lung Avoidance for Individualized Radiation Therapy: Results of a Double-Masked, Randomized Controlled Trial. International Journal of Radiation Oncology*Biology*Physics. 113(5). 1072–1084. 12 indexed citations

Chow, Ronald, Éduardo Bruera, Michael Sanatani, et al.. (2021). Cancer-related fatigue—pharmacological interventions: systematic review and network meta-analysis. BMJ Supportive & Palliative Care. 13(3). 274–280. 13 indexed citations

Sanatani, Michael, et al.. (2020). Quality of written feedback given to medical students after introduction of real-time audio monitoring of clinical encounters. BMC Medical Education. 20(1). 236–236. 1 indexed citations

10.

Uum, Stan Van, et al.. (2020). Percutaneous Cryoablation of Recurrent Pancreatic Mass for Life-Threatening Pancreatic VIPoma Syndrome: A Case Report. CardioVascular and Interventional Radiology. 44(1). 163–166. 1 indexed citations

11.

Moulin, Dwight E., et al.. (2017). Follow-up Visits and Changes in Pain Scores Reported by Oncology Outpatients After Initial Presentation With Severe Pain. Cureus. 9(1). e965–e965. 1 indexed citations

12.

Sanatani, Michael, Lauren Mai, Barbara Fisher, et al.. (2016). Severe myositis of the hip flexors after pre-operative chemoradiation therapy for locally advanced rectal cancer: case report. BMC Cancer. 16(1). 243–243. 7 indexed citations

13.

Zeng, Kang, Sara Kuruvilla, Michael Sanatani, & Alexander V. Louie. (2015). Bilateral Blindness Following Chemoradiation for Locally Advanced Oropharyngeal Carcinoma. Cureus. 7(10). e352–e352. 1 indexed citations

14.

Sanatani, Michael, et al.. (2014). Tolerability of the combination of ginger ( Zingiber officinalis ), gentian ( Gentiana lutea ) and turmeric ( Curcuma longa ) in patients with cancer-associated anorexia. Journal of Complementary and Integrative Medicine. 12(1). 57–60. 5 indexed citations

15.

Dingle, B., George Rodrigues, Mark Vincent, et al.. (2010). Analysis of a Novel Protocol of Combined Induction Chemotherapy and Concurrent Chemoradiation in Unresected Non–Small-Cell Lung Cancer: A Ten-Year Experience With Vinblastine, Cisplatin, and Radiation Therapy. Clinical Lung Cancer. 11(4). 243–250. 8 indexed citations

16.

Yu, Edward, Patricia Tai, Richard Malthaner, et al.. (2010). What Are the Factors that Predict Outcome at Relapse after Previous Esophagectomy and Adjuvant Therapy in High-Risk Esophageal Cancer?. Current Oncology. 17(6). 46–51. 7 indexed citations

17.

Yu, Edward, Patricia Tai, Jawaid Younus, et al.. (2009). Postoperative Extended-Volume External-Beam Radiation Therapy in High-Risk Esophageal Cancer Patients: A Prospective Experience. Current Oncology. 16(4). 48–54. 14 indexed citations

18.

Sanatani, Michael & Mark Vincent. (2007). Balancing Risk and Benefit for First-Line Treatment of Metastatic Colorectal Cancer: A Graphic Communication Tool for Patients and Physicians. PubMed. 4(2). 101–109. 2 indexed citations

19.

He, Lizhi, Catherine Fan, Michael Sanatani, et al.. (2007). Co-existence of high levels of the PTEN protein with enhanced Akt activation in renal cell carcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1772(10). 1134–1142. 25 indexed citations

20.

Sanatani, Michael, et al.. (1998). Elevated insulin-like growth factor (IGF) binding protein (IGFBP)-2 and IGFBP-4 expression of leukemic T-cells is affected by autocrine/paracrine IGF-II action but not by IGF type I receptor expression. European Journal of Endocrinology. 138(3). 337–343. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact